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Edited by Gianni CesareniAbstract Amino and carboxyl termini are unique positions in a
polypeptide. They tend to be exposed in folded three dimensional
structures. Diversity and functional signiﬁcance of C-terminal
sequences have been appreciated from studies of PDZ and
PEX domains. Signaling 14-3-3 protein signaling by recognizing
phosphorylated peptides plays a critical role in a variety of bio-
logical processes, including oncogenesis. The preferential binding
of 14-3-3 to phosphorylated C-terminal sequences, mode III,
provides a means of regulated binding and considerably expands
the substrate repertoire of 14-3-3 interaction partners.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Post-translational modiﬁcations of proteins are essential to
their proper regulation, localization, and function. One of
the most common types of post-translational modiﬁcations is
phosphorylation of serine or threonine amino acids. Phosphor-
ylation may aﬀect a protein in a variety of ways including fold-
ing, stability, interactions, and activities (see review by Pawson
and Scott [1]). A common mechanism to achieve these changes
is through protein–protein interactions. The ﬁrst protein with a
property of preferentially recognizing phosphorylated target
proteins is 14-3-3 [2]. The 14-3-3 proteins were originally iden-
tiﬁed from brain because of their abundance and unusual acid-
ity [3]. In human, there are seven 14-3-3 isoforms (b, c, e, f, g,
s, r). They are highly homologous proteins, with approxi-
mately 50% amino acid identity, capable of forming either
homo- or heterodimers. Evidence from both structural studies
and sequence analyses support the notion that the primary
function of 14-3-3 proteins lies in their preferential binding
to phosphorylated substrates and their geometrically oriented
bivalent binding sites formed by dimerization.
More than 300 proteins have been reported to interact with
14-3-3 and these proteins are known for their functions in a vari-*Corresponding author. Fax: +1 410 614 1001.
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interactions thus far are mediated by two canonical internal
binding motifs, mode I (RSXpSXP) and mode II (RXUXpSXP)
(U as an aromatic or aliphatic amino acid, X as any amino acid)
(Fig. 1A). Their targeted sequences contain either phosphoser-
ine or phosphothreonine [2,6]. As discussed in detail below, a
number of earlier reports recognize the interactions between
14-3-3 and protein C-termini (see below). A crystallographic
structure of 14-3-3 binding to C-terminus was also obtained
[7]. With increasing evidence of speciﬁc and functional interac-
tions between protein C-termini and 14-3-3, this characteristic
binding is thus proposed as mode III [8]. Recent evidence fur-
ther indicates that some mode III binding displays comparable
binding aﬃnity to that of modes I and II binding and they
function independently [9]. Therefore, the mode III binding is
unique and likely to represent a signiﬁcant expansion of the
14-3-3 binding repertoire and thus functions.2. C-terminal mode III binding
Hints of C-terminal binding to 14-3-3 were recognized from
several lines of early evidence. First, the Iba subunit of glyco-
protein complex Ib-IX-V [10], where a synthetic peptide con-
taining only the C-terminal 15 residues from the Iba subunit
was shown to bind to puriﬁed 125I-labeled 14-3-3f. Recombi-
nant Iba subunit lacking the last 5 residues (606SGHSL-
COOH) can no longer bind to 14-3-3. Intriguingly, the
synthetic peptide used in the study was not phosphorylated.
It was suggested as a non-canonical, phosphorylation-indepen-
dent binding motif based on a cluster of serine residues. More
deﬁnitively, the ﬁnal four residues (GHSL-COOH) were suﬃ-
cient for 14-3-3f binding and mutation of any one residue
abolishes the binding using a radioisotope aﬃnity pull-down
competition assay [11]. Recent evidence from an Iba pS609
speciﬁc antibody indicates that, while non-phosphorylated
Iba may have some aﬃnity for 14-3-3f, in vivo Iba is primarily
phosphorylated [12]. Furthermore, Iba with pS609 has a greater
aﬃnity for 14-3-3f as demonstrated by competition with pep-
tides corresponding to the last 15 aa of the Iba protein [12].
Regardless of the phosphorylation state of Iba, it is clear that
the Iba C-terminus is not the sole 14-3-3 binding site in the Ib-
IX-V complex [11,13].
Another early study recognizing a C-terminal 14-3-3 binding
motif came from investigating the regulation of the plant plasma
membrane H+-ATPase by 14-3-3. The consensus sequence forblished by Elsevier B.V. All rights reserved.
Fig. 1. Internal and C-terminal 14-3-3 binding motifs. (A) The internal
mode I and mode II peptide motifs contain a turn inducing proline
(red) that directs the peptide out of the 14-3-3 binding groove. (B) The
C-terminal mode III peptide motif avoids continuing down the 14-3-3
binding groove by simple termination. The mode III diagram is based
on homology modeling using the existing crystal structure of 14-3-3 [9].
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COOH, a highly conserved motif among diﬀerent plant species
and isoforms [14]. Mutation of the Thr to Ala abolished the
binding to 14-3-3, suggesting the potential phosphorylation.
It is believed that the binding of 14-3-3 to plant plasma mem-
brane H+-ATPase activates the proton pump by preventing the
function of a C-terminal autoinhibitory domain [15–17]. The
weak interaction between 14-3-3 and H+-ATPase could be
potentiated by the binding of a fungal toxin, fusicoccin, which
leads to a tripartite complex [18–20]. The crystal structure for
this tripartite complex provides a structural view of a C-termi-
nal 14-3-3 binding motif and compatibility of phosphothreo-
nine for the interaction [7]. In addition to the C-terminal
QQXYpTV-COOH motif, an internal 14-3-3 binding site in
H+-ATPase has been reported. In fact, the binding of both
C-terminus and additional upstream internal site(s) is required
for the physiological regulation of plant plasma membrane
H+-ATPases by 14-3-3 [21,22].
An interaction between interleukin 9 receptor alpha chain
(IL-9Ra) and 14-3-3f was identiﬁed via a yeast two-hybrid
screen. Truncation of the ﬁve C-terminal residues of IL-9Ra
abolished the interaction [23]. There are two phosphorylation
sites at the C-terminus of IL-9Ra. Phosphopeptides of
either of two sites (MLLPSVLSKARSWpTF-COOH or
MLLPSVLSKARpSWTF-COOH) were capable of 14-3-3
binding. While competition assays support the higher aﬃnity
for the phosphothreonine motif, it remains to be determined
which residue or whether both residues are phosphorylated
in cells [23].
Surface expression of two potassium channels, KCNK3 and
KCNK9, requires an intact C-terminus, RRSpSV-COOH
(KCNK3) and RRKpSV-COOH (KCNK9). Indeed, these mo-
tifs are capable of binding to 14-3-3 [24,25]. The requirement
of phosphorylation for 14-3-3 binding was demonstrated using
synthetic peptides as substrates. Additionally, truncation of
the terminal valine eliminated the 14-3-3 binding. The ability
of 14-3-3 binding is directly correlated with the surface expres-
sion.
Using a genetic screen of random peptide sequences, Shik-
ano et al. recently identiﬁed a family of peptides, known asSWTY, with a robust ability to override endoplasmic reticu-
lum (ER) localization and confer surface expression. The
SWTY peptide binds to 14-3-3 in a phosphorylation-depen-
dent manner [26]. Furthermore, the dissociation constant
(KD) of RGRSWpTY-COOH binding to 14-3-3 is 0.17 lM,
comparable to the values measured for mode I and II interac-
tions [9,27]. The consensus sequence has allowed identiﬁcation
of native C-terminal 14-3-3 binding motifs through informat-
ics. Their roles in interaction with 14-3-3 have been experimen-
tally demonstrated [26].
The binding of 14-3-3 to protein C-termini also is implicated
in subcellular localization of soluble proteins, exempliﬁed by
the cyclin-dependent kinase inhibitor p27Kip1 [28]. The binding
of 14-3-3 to the C-terminal motif RRRQpT-COOH causes a
cytoplasmic localization of p27Kip1, thereby preventing its
activity in the nucleus. The evidence for phosphorylation of
the terminal threonine came from pharmacological experi-
ments manipulating upstream kinases or phosphatases, as well
as from a p27Kip1 T198A mutant.
Geometrically oriented, the two binding sites in a 14-3-3 di-
mer may constrain a targeted molecule in a certain conforma-
tion, providing a means to regulate an enzyme. Both structure
and binding studies support that ovine arylalkylamin N-acetyl-
transferase (oAANAT), the penultimate enzyme in melatonin
synthesis, has two binding sites to 14-3-3f, and presumably,
follows one enzyme per dimeric 14-3-3 stoichiometry [8,29].
The interesting aspect of this study came from initial recogni-
tion of 14-3-3 binding to an internal region (via mode II) and
the coordinated phosphorylation under physiologically rhyth-
mic cycles. The virtue of 14-3-3 binding causes considerable
changes in enzymatic activities and stability, hence exerting
the physiological function. The binding aﬃnity to the C-termi-
nal site (202RRNpSDR-COOH) appears to be very low, but
detectable, as determined by radioisotope aﬃnity pull-down
assays [8]. The resultant non-saturated binary binding of 14-
3-3 to these sites was suggested as a tuning mechanism for
rhythmic enzyme activity that is coordinated with the daily cy-
cle of melatonin production [8].3. Consensus sequence for mode III
Based on the similarity between the C-terminal 14-3-3 bind-
ing motifs of the oAANAT (RRNpSDR-COOH) and H+-
ATPase (QQXYpTV-COOH) proteins, a mode III consensus
for 14-3-3 binding (pSX1–2-COOH) has been proposed [8].
The focal points of this consensus are that the motif is at
the C-terminus, and binding is phosphorylation-dependent.
Two-site binding is also a common factor for both oAANAT
and H+-ATPase, for which the C-terminal interaction alone is
of low aﬃnity. The evidence of SWTY motif interaction with
14-3-3 demonstrates that mode III motifs are capable of sin-
gle site binding similar to modes I and II. In fact, the mode
III binding by SWTY motif has higher aﬃnity compared to
that of pS-Raf259 or pS-Raf621 peptides [27]. Amino acid
selectivity upstream of the phosphorylated residue is conspic-
uously absent from the proposed mode III motif, presumably
due to the discrepancy between the oAANAT and H+-ATP-
ase motifs. Upstream arginine residues are preferred for 14-3-
3 binding as determined by random synthetic peptide library
screening [6] and by random peptide selection in a cell-based
genetic screen [26]. In a crystal structure with 14-3-3, a mode
Table 1
C-terminal 14-3-3 binding motifs
Iba subunit of glycoprotein
complex Ib-IX-V
SIRYSGHpSL-COOHa [12]
IL-9Ra (2 alternative
phosphorylation sites)
MLLPSVLSKARSWpTF-COOH [23]
MLLPSVLSKARpSWTF-COOH [23]
Plant plasma membrane
H+-ATPase (consensus)
QQXYpTV-COOHb [7,14,19,43]
KCNK3 RRSpSV-COOH [24,26]
KCNK9 RRKpSV-COOH [24]
p27Kip1 RRRQpT-COOH [28]
oAANAT RRNpSDR-COOH [8]
SWTYc RGRSWpTY-COOH [9,26]
GPR15 ARRRKRSVpSL-COOHd [26]
aThe Iba subunit C-terminus has also shown a phosphorylation-
independent interaction with 14-3-3, for which the last 4 residues
(GHSL-COOH) are suﬃcient [10,11].
bThe X represents the diversity between the many homologs and
orthologs in various plant species. Residues found in this position
include, His, Ser, Ala, and Asn.
cSWTY is the name for the 7aa motif selected from a yeast random
peptide screen.
dThe length of this motif is not yet reﬁned by mutagenesis studies, the
10aa length is functional in a reporter construct.
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(RLYHpSLPA) that was looped back to interact with the
phosphate on the peptide [30]. Similarly, in a recent structure
with a non-canonical peptide from histone H3
(RKpSTGGK), the -2 arginine also looped back to interact
with the phosphate of the peptide [31]. These lines of
evidence support the contribution of upstream arginines to
14-3-3 aﬃnity. However, the arginine is absent in plant H+-
ATPase, suggesting it is not a absolute requirement. For all
three modes of 14-3-3 binding phosphorylation is a prerequi-
site, and arginines located upstream of the phosphorylated
Ser/Thr are also important for recognition by a number of ki-
nases [32]. It is possible that plant and animal diﬀer signiﬁ-
cantly in kinase recognition. Alanine-scanning mutagenesis
of the SWTY motif demonstrated the importance of the up-
stream arginines for phosphorylation-dependent 14-3-3 bind-
ing in HEK293 cells [26]. As more mode III motifs become
available, it would be valuable to revisit the issue of upstream
sequence requirements both in terms of binding per se and in
terms of kinase recognition.
The ﬁrst residue C-terminal to the phosphoserine or phos-
phothreonine (pS+1 position) has been represented as X (any
residue) in all three modes of binding. Screening for optimal
mode II binding peptides from random synthetic phospho-
peptides shows that this position has high abundance for L/
E/A/M [2,6]. To experimentally determine the selectivity at
the pS+1 position in mode III binding, the SWTY motif
was mutated and tested individually with the 20 diﬀerent ami-
no acids at that C-terminal position (RGRSWpTX-COOH)
[9]. In this study, cell-based assays, which rely on kinase
activity prior to 14-3-3 binding, led to the conclusion that,
with the exception of proline, all amino acids are acceptable
at the pS+1 position. Mutants with Glu, Asp, and Gly at this
position have reduced surface expression. The relative order
of function in the cell-based assay correlated with peptide
aﬃnity determined by synthetic phosphopeptides, suggesting
that at least for SWTY motif, the kinase could not discrimi-
nate the C-terminal residues [9,27]. Noticeably, the preference
in the SWTY mode III motif at the pS+1 position is diﬀerent
from that determined by random synthetic peptide screens
that prefer L/E/A/M. It remains to be seen whether the deter-
mined selectivity proﬁle at the pS+1 position will apply to
other mode III motifs and how an additional amino acid
downstream, as in the case of the oAANAT motif
(RRNpSDR-COOH), may contribute to the selectivity (see
Table 1).
The proline at the pS+2 position in modes I and II is thought
to have an important contribution to 14-3-3 binding in that it
causes a turn of the peptide out of the 14-3-3 binding groove,
presumably preventing steric hindrance [30]. Mode III se-
quences avoid such hindrance by truncation, eliminating the
need for a turn out of the groove (Fig. 1). In this case, the
allowable number of amino acids following the phosphory-
lated residue is not well established, because few motifs have
been identiﬁed thus far. From the genetic screen that identiﬁed
SWTY, one residue seems to be preferable [9]. An elongated
form of the SWTY motif, RGRSWpTYAAA-COOH failed
to function either in a synthetic peptide binding assay or in
the cell-based surface expression, suggesting that the presence
of four amino acids following pT is not compatible with 14-3-3
binding [26]. However, the existing evidence could not rule out
that residues at the pT + 3 and pT + 4 positions simply have alimited number of compatible amino acids or that an alanine
residue(s) adversely aﬀects the binding.4. Aﬃnity and valency of interactions
The aﬃnity of 14-3-3 interactions is crucial to its function,
especially in distinguishing phosphorylated from non-phos-
phorylated forms. For the SWTY motif, the diﬀerence in aﬃn-
ity is more than 100-fold [9]. In several well-characterized
interactions, bivalent binding via dimeric 14-3-3 proteins in-
volves two diﬀerent binding sites. In some enzymes, the bind-
ing and catalysis involves two distinct sites. The initial
binding of targeted substrates greatly facilitates the subsequent
recognition and catalysis [33]. Because many enzymes such as
kinases and phosphatases are promiscuous in substrate recog-
nition, the binding confers the speciﬁcity of catalysis. This has
also motivated the notion of step-wise engagement for 14-3-3
interaction [6].
Precise determination of binding constants is critical for full
understanding of 14-3-3 function for several reasons. First,
there is considerable diversity of binding proteins or sequences
suggesting an adaptor function for 14-3-3 (Fig. 2A) [34]. Many
well-characterized interactions, such as Raf-14-3-3 [6] and AN-
NAT-14-3-3 [8], involve binding of one 14-3-3 dimer to two
diﬀerent sites (Fig. 2B). Second, a number of examples are pro-
posed where 14-3-3 binding competes against or masks a target
from other interactions (see review by Bridges and Moorhead,
[35]). Recently the direct interaction of 14-3-3 with the nuclear
localization sequence (NLS) of FoxO4 protein was demon-
strated using ﬂuorophore-labeled FoxO4 NLS [36]. Further-
more, Yuan et al. have shown stoichiometric binding of
14-3-3 to tetrameric substrate and a lack of eﬀective binding
to monomeric substrate is critical for ER localization activity
of RKR motif [37]. Therefore, relative aﬃnity is critical for
the physiological outcome.
Methods for measuring 14-3-3 aﬃnity vary considerably,
making comparisons of diﬀerent ﬁndings diﬃcult. Some tech-
niques utilize certain speciﬁc characteristics, like 14-3-3 bind-
ing-regulated enzyme activity [29]. Other techniques include
quantitative aﬃnity precipitation [2] and surface plasmon
Fig. 2. 14-3-3 may bind to proteins that contain one or two target sites. (A) Binding to a protein with one target site may mask the protein from other
interactions (upper). Multiple proteins with single target sites may be colocalized by binding to the same 14-3-3 dimer (lower). (B) A protein with two
target sites may demonstrate cooperative binding to 14-3-3. In this case functional consequences may include a conformational change (activating or
inactivating) or masking of other interactions.
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a solid phase [38,39]. While solid phase (heterogenous) assays
provide a useful assessment of relative aﬃnities, immoblization
of binding partners on a surface often leads to overestimation
of binding aﬃnities as seen in both 14-3-3 and PDZ binding
[31,40]. These measurements are not compatible to that ob-
tained by microcalorimetry, a preferred method, because it is
both solution-based (homogenous) and label-free. The caveat
to the current microcalorimetry technique is that it requires
considerable amounts of materials. Recently, a ﬂuorescence
polarization method was reported using ﬂuorophore-labeled
peptide (FAM-RGRSWpTY-COOH) to enable solution-based
measurement of aﬃnities with small quantities of materials
[9,27]. The combination of a solution-based format, mix-and-
read capability, and the minimal material requirement aﬀords
its general applicability, including high throughput screens.5. Conclusion
C-terminal 14-3-3 binding motifs have become a recognized
group with a distinct mode of interaction. They interact withthe same ligand-binding groove of 14-3-3 as do the canonical
mode I and mode II motifs [9]. This interaction requires
phosphorylation, contrasting with C-terminal recognition by
PDZ domain or PEX domain [41]. Existing mode III peptides
have a general consensus of p(S/T)X12-COOH. For the
mode III binding sites found in animals, upstream arginine
residues are frequently present, presumably contributing to
both 14-3-3 interaction and kinase recognition. Although this
is a highly degenerate motif, the restricted C-terminal loca-
tion enables bioinformatic identiﬁcation of more mode III
peptides from protein databases [26,42]. As more mode III
14-3-3 binding proteins continue to be identiﬁed, new insights
into the general mechanisms of action may be discovered,
especially in the context of the signaling events and kinases
that recognize speciﬁc C-terminal sequences and confer 14-
3-3 interactions.
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